Beck M T, Holle L, Chen W Y
Clemson University, SC, USA.
Biotechniques. 2001 Oct;31(4):782-4, 786. doi: 10.2144/01314st04.
PCR subtraction hybridization has been used effectively to enrich and single out differentially expressed genes. However identification of these genes by means of cloning and sequencing individual cDNAs is a tedious and lengthy process. In this report, an attempt has been made to combine the use of PCR select cDNA subtraction hybridization and cDNA microarrays to identify differentially expressed genes using a nonradioactive chemiluminescent detection method. mRNA from human prolactin (hPRL) or human prolactin antagonist (hPRL-G129R) treated and non-treated breast cancer cells was isolated, and cDNAs were synthesized and used for the PCR subtraction to enrich the differentially expressed genes in the treated cells. The PCR-amplified and subtracted cDNA pools were purified and labeled using the digoxigenin method. Labeled cDNAs were hybridized to a human apoptosis cDNA microarray membrane and identified by chemiluminescence. The results suggest that the strategy of combining all three methods will allow for a more efficient, nonradioactive way of identifying differentially expressed genes in target cells.
聚合酶链反应消减杂交已被有效地用于富集和筛选差异表达基因。然而,通过克隆和测序单个互补DNA(cDNA)来鉴定这些基因是一个繁琐且漫长的过程。在本报告中,已尝试将PCR选择cDNA消减杂交与cDNA微阵列结合使用,采用非放射性化学发光检测方法来鉴定差异表达基因。从经人催乳素(hPRL)或人催乳素拮抗剂(hPRL-G129R)处理和未处理的乳腺癌细胞中分离出信使核糖核酸(mRNA),合成cDNA并用于PCR消减,以富集处理后细胞中的差异表达基因。对PCR扩增和消减后的cDNA文库进行纯化,并用洋地黄毒苷法进行标记。将标记的cDNA与人类凋亡cDNA微阵列膜杂交,通过化学发光进行鉴定。结果表明,将这三种方法结合的策略将提供一种更高效、非放射性的方法来鉴定靶细胞中的差异表达基因。